Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 201-225 of 643 matching filings.

Per page
25
Current page
9
8-K File 001-36845

8-K

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
20 Mar 2020
Reporting date
20 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
10 Mar 2020
Reporting date
10 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
18 Feb 2020
Reporting date
18 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A filing

Filing date
10 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
07 Feb 2020
Reporting date
05 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
29 Jan 2020
Reporting date
29 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2020
Reporting date
23 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36845

DEF 14A

Filing date
07 Jan 2020
Reporting date
07 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36845

PRE 14A

Filing date
27 Dec 2019
Reporting date
27 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
17 Dec 2019
Reporting date
17 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2019
Reporting date
21 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
06 Nov 2019
Reporting date
06 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Oct 2019
Reporting date
24 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Oct 2019
Reporting date
24 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
23 Oct 2019
Reporting date
23 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .